Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +42.07%
#2 0G 0G +32.62%
#3 Zora Zora +21.70%
#4 Nockchain Nockchain +19.74%
#5 Fake World Assets Fake World Assets +19.23%
#6 Notcoin Notcoin +18.05%
#7 Full Moon Full Moon +17.17%
#8 Axelar Axelar +16.37%
#9 VVS Finance VVS Finance +15.88%
#10 ADO Protocol ADO Protocol +15.63%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
Clasificación en acciones #12971
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Precio por acción
$0.66137861
Capitalización bursátil
$531.70M
Cambio (1 día)
-2.45%
Cambio (1 año)
-42.12%
País
CN
Comercio Ocumension Therapeutics (1477)

Categoría

Healthcare
Ingresos de Ocumension Therapeutics (1477)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Ocumension Therapeutics, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Ocumension Therapeutics desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH